(December 19, 2017, 10:34 AM EST) -- NEW ORLEANS — The judge overseeing the Xarelto multidistrict litigation on Dec. 14 denied a motion for a new trial by the plaintiff in the third bellwether trial, finding, among other things, that the plaintiff’s “newly discovered evidence” is actually cumulative of previously known and admitted evidence (In Re: Xarelto [Rivaroxaban] Products Liability Litigation, MDL Docket No. 2592, E.D. La., 2017 U.S. Dist. LEXIS 205422)....